Tokyo Tape
Sign in
← Muromachi Chemicals

Annual report

4885.TEDINET S100UA72
Period2023-06-01 → 2024-05-31
Filed2024-08-28
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 95
MetricValuePeriodScopeSource row
Revenue¥6.4bn2023-06-01 → 2024-05-31StandaloneNet sales
Revenue¥6.3bn2022-06-01 → 2023-05-31StandaloneNet sales
Revenue¥5.7bn2021-06-01 → 2022-05-31dStandaloneNet sales (5-year summary)
Revenue¥4.9bn2020-06-01 → 2021-05-31dStandaloneNet sales (5-year summary)
Revenue¥5.3bn2019-06-01 → 2020-05-31dStandaloneNet sales (5-year summary)
Operating income¥422m2023-06-01 → 2024-05-31StandaloneOperating income
Operating income¥369m2022-06-01 → 2023-05-31StandaloneOperating income
Ordinary income¥428m2023-06-01 → 2024-05-31StandaloneOrdinary income
Ordinary income¥351m2022-06-01 → 2023-05-31StandaloneOrdinary income
Ordinary income¥423m2021-06-01 → 2022-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥339m2020-06-01 → 2021-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥272m2019-06-01 → 2020-05-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥278m2019-06-01 → 2020-05-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥469m2023-06-01 → 2024-05-31StandaloneIncome before income taxes
Profit before tax¥351m2022-06-01 → 2023-05-31StandaloneIncome before income taxes
Net income (owners)¥32m2019-06-01 → 2020-05-31dStandaloneProfit loss attributable to owners of parent (5-year summary)
Net income¥330m2023-06-01 → 2024-05-31StandaloneProfit loss
Net income¥256m2022-06-01 → 2023-05-31StandaloneProfit loss
Net income¥456m2021-06-01 → 2022-05-31dStandaloneNet income loss (5-year summary)
Net income¥181m2020-06-01 → 2021-05-31dStandaloneNet income loss (5-year summary)
Net income¥34m2019-06-01 → 2020-05-31dStandaloneNet income loss (5-year summary)
Total assets¥5.1bnat 2024-05-31StandaloneAssets
Total assets¥4.9bnat 2023-05-31StandaloneAssets
Total assets¥4.8bnat 2022-05-31dStandaloneTotal assets (5-year summary)
Total assets¥4.6bnat 2021-05-31dStandaloneTotal assets (5-year summary)
Total assets¥4.8bnat 2020-05-31dStandaloneTotal assets (5-year summary)
Total liabilities¥2.8bnat 2024-05-31StandaloneLiabilities
Total liabilities¥3.0bnat 2023-05-31StandaloneLiabilities
Net assets / equity¥2.3bnat 2024-05-31StandaloneNet assets
Net assets / equity¥1.9bnat 2023-05-31StandaloneNet assets
Net assets / equity¥1.7bnat 2022-05-31dStandaloneNet assets
Net assets / equity¥1.3bnat 2021-05-31dStandaloneNet assets (5-year summary)
Net assets / equity¥252mat 2020-05-31dStandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2024-05-31StandaloneCash and deposits
Cash and deposits¥853mat 2023-05-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2024-05-31StandaloneCash and cash equivalents
Cash & equivalents¥853mat 2023-05-31StandaloneCash and cash equivalents
Cash & equivalents¥865mat 2022-05-31dStandaloneCash and cash equivalents
Cash & equivalents¥1.0bnat 2021-05-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥881mat 2020-05-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥638m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥317m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in operating activities
Operating cash flow¥525m2021-06-01 → 2022-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥488m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥89m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥232m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥162m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in investment activities
Investing cash flow−¥176m2021-06-01 → 2022-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥58m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow¥137m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow−¥210m2023-06-01 → 2024-05-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥172m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in financing activities
Financing cash flow−¥484m2021-06-01 → 2022-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥311m2020-06-01 → 2021-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥42m2019-06-01 → 2020-05-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥83.422023-06-01 → 2024-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-06-01 → 2023-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥123.792021-06-01 → 2022-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥65.242020-06-01 → 2021-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥15.752019-06-01 → 2020-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥17.162019-06-01 → 2020-05-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥81.862023-06-01 → 2024-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥64.122022-06-01 → 2023-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥112.562021-06-01 → 2022-05-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥56.972020-06-01 → 2021-05-31dStandaloneDiluted earnings per share (5-year summary)
Dividend per share¥222023-06-01 → 2024-05-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥192022-06-01 → 2023-05-31StandaloneDividend paid per share (5-year summary)
Dividend per share¥192021-06-01 → 2022-05-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥152020-06-01 → 2021-05-31dStandaloneDividend paid per share (5-year summary)
Dividend per share¥32019-06-01 → 2020-05-31dStandaloneDividend paid per share (5-year summary)
Net assets per share¥571.26at 2024-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥487.25at 2023-05-31StandaloneNet assets per share (5-year summary)
Net assets per share¥450.37at 2022-05-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥363.93at 2021-05-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥101.92at 2020-05-31dStandaloneNet assets per share (5-year summary)
Equity ratio44.9%at 2024-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio38.7%at 2023-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.0%at 2022-05-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio28.9%at 2021-05-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio5.3%at 2020-05-31dStandaloneEquity to asset ratio (5-year summary)
ROE15.8%2023-06-01 → 2024-05-31StandaloneRate of return on equity (5-year summary)
ROE14.3%2022-06-01 → 2023-05-31StandaloneRate of return on equity (5-year summary)
ROE30.3%2021-06-01 → 2022-05-31dStandaloneRate of return on equity (5-year summary)
ROE22.8%2020-06-01 → 2021-05-31dStandaloneRate of return on equity (5-year summary)
ROE16.0%2019-06-01 → 2020-05-31dStandaloneRate of return on equity (5-year summary)
Shares issued4,095,500at 2024-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-05-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2021-05-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued775,000at 2020-05-31dStandaloneTotal number of issued shares (5-year summary)
Employees205at 2024-05-31StandaloneNumber of employees
Employees205at 2023-05-31StandaloneNumber of employees
Employees197at 2022-05-31dStandaloneNumber of employees
Employees195at 2021-05-31dStandaloneNumber of employees
Employees196at 2020-05-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 53
SegmentItemPeriodValue
Reconciling Itemsreconcilingsegment assetsat 2024-05-31¥1.6bn
Chemical Products Businessreportable segmentcapex2023-06-01 → 2024-05-31¥77m
Chemical Products Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥56m
Chemical Products Businessreportable segmentemployeesat 2024-05-3154 pure
Chemical Products Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥2.3bn
Chemical Products Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥2.3bn
Chemical Products Businessreportable segmentsegment assetsat 2024-05-31¥1.1bn
Chemical Products Businessreportable segmentsegment profit2023-06-01 → 2024-05-31−¥16m
Healthy Food Businessreportable segmentcapex2023-06-01 → 2024-05-31¥15m
Healthy Food Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥27m
Healthy Food Businessreportable segmentemployeesat 2024-05-3119 pure
Healthy Food Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥834m
Healthy Food Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥834m
Healthy Food Businessreportable segmentsegment assetsat 2024-05-31¥473m
Healthy Food Businessreportable segmentsegment profit2023-06-01 → 2024-05-31−¥38m
Pharmaceutical Businessreportable segmentcapex2023-06-01 → 2024-05-31¥198m
Pharmaceutical Businessreportable segmentdepreciation2023-06-01 → 2024-05-31¥54m
Pharmaceutical Businessreportable segmentemployeesat 2024-05-3153 pure
Pharmaceutical Businessreportable segmentrevenue2023-06-01 → 2024-05-31¥3.3bn
Pharmaceutical Businessreportable segmentrevenue external2023-06-01 → 2024-05-31¥3.3bn
Pharmaceutical Businessreportable segmentsegment assetsat 2024-05-31¥1.9bn
Pharmaceutical Businessreportable segmentsegment profit2023-06-01 → 2024-05-31¥476m
Total Of Reportable Segments And Otherssegment totalcapex2023-06-01 → 2024-05-31¥289m
Total Of Reportable Segments And Otherssegment totaldepreciation2023-06-01 → 2024-05-31¥136m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-05-31¥6.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-05-31¥6.4bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2024-05-31¥3.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-05-31¥422m
Reconciling Itemsreconcilingsegment assetsat 2023-05-31¥1.3bn
Chemical Products Businessreportable segmentcapex2022-06-01 → 2023-05-31¥37m
Chemical Products Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥50m
Chemical Products Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥2.1bn
Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥2.1bn
Chemical Products Businessreportable segmentsegment assetsat 2023-05-31¥1.2bn
Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2023-05-31−¥50m
Healthy Food Businessreportable segmentcapex2022-06-01 → 2023-05-31¥17m
Healthy Food Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥28m
Healthy Food Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥658m
Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥658m
Healthy Food Businessreportable segmentsegment assetsat 2023-05-31¥395m
Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2023-05-31−¥120m
Pharmaceutical Businessreportable segmentcapex2022-06-01 → 2023-05-31¥128m
Pharmaceutical Businessreportable segmentdepreciation2022-06-01 → 2023-05-31¥45m
Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2023-05-31¥3.5bn
Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2023-05-31¥3.5bn
Pharmaceutical Businessreportable segmentsegment assetsat 2023-05-31¥2.0bn
Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2023-05-31¥539m
Total Of Reportable Segments And Otherssegment totalcapex2022-06-01 → 2023-05-31¥181m
Total Of Reportable Segments And Otherssegment totaldepreciation2022-06-01 → 2023-05-31¥122m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-05-31¥6.3bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-05-31¥6.3bn
Total Of Reportable Segments And Otherssegment totalsegment assetsat 2023-05-31¥3.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-05-31¥369m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,231
ItemContextValueUnit
Independent auditors report non consolidated (text)FilingDateInstantText · Plus
Audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)有限責任監査法人ト　ー　マ　ツ
Cpa1 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)寺　　田　　篤　　芳
Cpa2 audit firm1 non consolidatedFilingDateInstant
Original text (Japanese)宮　　嵜　　　 健
Key audit matters non consolidated (text)FilingDateInstantText · Plus
Overview kam non consolidated (text)FilingDateInstantText · Plus
Short description kam non consolidatedFilingDateInstant_Row1Member
Original text (Japanese)固定資産に関する減損会計の適用
Description including reason kam non consolidated (text)FilingDateInstant_Row1MemberText · Plus
Reference kam non consolidatedFilingDateInstant_Row1Member
Original text (Japanese)重要な会計上の見積り
Auditors response kam non consolidated (text)FilingDateInstant_Row1MemberText · Plus
Other information non consolidated (text)FilingDateInstantText · Plus
Fee related information non consolidated (text)FilingDateInstantText · Plus
Number of submissionFilingDateInstant1
Net sales (5-year summary)Prior4YearDuration5280306000JPY
Net sales (5-year summary)Prior3YearDuration－JPY
Net sales (5-year summary)Prior2YearDuration－JPY
Net sales (5-year summary)Prior1YearDuration－JPY
Net sales (5-year summary)CurrentYearDuration－JPY
Ordinary income loss (5-year summary)Prior4YearDuration271851000JPY
Ordinary income loss (5-year summary)Prior3YearDuration－JPY
Ordinary income loss (5-year summary)Prior2YearDuration－JPY
Ordinary income loss (5-year summary)Prior1YearDuration－JPY
Ordinary income loss (5-year summary)CurrentYearDuration－JPY
Profit loss attributable to owners of parent (5-year summary)Prior4YearDuration31570000JPY
Profit loss attributable to owners of parent (5-year summary)Prior3YearDuration－JPY
Profit loss attributable to owners of parent (5-year summary)Prior2YearDuration－JPY
Profit loss attributable to owners of parent (5-year summary)Prior1YearDuration－JPY
Profit loss attributable to owners of parent (5-year summary)CurrentYearDuration－JPY
Comprehensive income (5-year summary)Prior4YearDuration21397000JPY
Comprehensive income (5-year summary)Prior3YearDuration－JPY
Comprehensive income (5-year summary)Prior2YearDuration－JPY
Comprehensive income (5-year summary)Prior1YearDuration－JPY
Comprehensive income (5-year summary)CurrentYearDuration－JPY
Net assets (5-year summary)Prior4YearInstant－JPY
Net assets (5-year summary)Prior3YearInstant－JPY
Net assets (5-year summary)Prior2YearInstant－JPY
Net assets (5-year summary)Prior1YearInstant－JPY
Net assets (5-year summary)CurrentYearInstant－JPY
Total assets (5-year summary)Prior4YearInstant－JPY
Total assets (5-year summary)Prior3YearInstant－JPY
Total assets (5-year summary)Prior2YearInstant－JPY
Total assets (5-year summary)Prior1YearInstant－JPY
Total assets (5-year summary)CurrentYearInstant－JPY
Net assets per share (5-year summary)Prior4YearInstant－
Net assets per share (5-year summary)Prior3YearInstant－
Net assets per share (5-year summary)Prior2YearInstant－
Net assets per share (5-year summary)Prior1YearInstant－
Net assets per share (5-year summary)CurrentYearInstant－
Basic earnings loss per share (5-year summary)Prior4YearDuration15.75
Basic earnings loss per share (5-year summary)Prior3YearDuration－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 13 of 13 passed
balance sheet identitynon_consolidated 2023-05-31pass
balance sheet identitynon_consolidated 2024-05-31pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2022-05-31pass
statement vs summary · net assetsnon_consolidated 2023-05-31pass
statement vs summary · net assetsnon_consolidated 2024-05-31pass
statement vs summary · operating cash flownon_consolidated 2022-06-01/2023-05-31pass
statement vs summary · operating cash flownon_consolidated 2023-06-01/2024-05-31pass
statement vs summary · revenuenon_consolidated 2022-06-01/2023-05-31pass
statement vs summary · revenuenon_consolidated 2023-06-01/2024-05-31pass
statement vs summary · total assetsnon_consolidated 2023-05-31pass
statement vs summary · total assetsnon_consolidated 2024-05-31pass